Rapid weight loss can affect medication needs, blood glucose stability, and overall health outcomes
The control group was significantly different than the current time point for both medications (Semaglutide: B = 10.29, SE = 3.02, p = 0.004, Tirzepatide: B = 11.445, SE = 3.08, p = 0.003), but was not different when compared to prior to starting each medication (n.s.)
According to Pfizer, the enzymes returned to normal after the patient ceased taking danuglipron
Long-Term Insulin Use The most consequential rule: ICD-10 Code Z79.4 must NOT be assigned when insulin is given temporarily to bring a Type 2 patients blood sugar under control during a single encounter
Codella R et al
3.0%6.6% and 0.4% of patients in the respective groups discontinued treatment because of these adverse events (54)